Abstract
Purpose
The NOD2 gene is known to have a strong association with Crohn’s disease, but different trends were reported in occurrence of NOD2 variants in distinct ethnicities. The aim of this study was to assess all exonic sequences of the NOD2 gene in Iranian Crohn's disease patients and healthy controls to identify any existing variation and evaluate their association with Crohn's disease.
Methods
A total of 90 non-related Crohn's disease patients and 120 sex- and age-matched healthy controls of Iranian origin were enrolled in this study. The participants were referred to a tertiary center in a 2-year period (2006–2008). The exonic regions of the NOD2 gene were amplified by polymerase chain reaction and evaluated by direct sequencing.
Results
A total of 21 sequence variations were identified among all exonic regions of the NOD2 gene, of which eight had an allele frequency of more than 5%. Eight new mutations (one in exon 2 and seven in exon 4) were observed. The three main variants (R702W, G908R, and 1007fs) showed allele frequencies of 13.3%, 2.2%, and 1.7%, respectively. Three new variations (P371T, A794P, and Q908H) and R702W mutation were significantly more frequent in Crohn's disease patients compared to controls.
Conclusions
Eight novel mutations were identified in the NOD2 exons, but the pathophysiological importance of these variants remains unclear. Iranian patients with their different genetic reservoirs may demonstrate some novel characteristics for disease susceptibility.
Similar content being viewed by others
References
Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347(6):417–429
Bonen DK, Cho JH (2003) The genetics of inflammatory bowel disease. Gastroenterology 124:521–536
Hugot JP, Cézard JP, Colombel JF et al (2003) Clustering of Crohn’s disease within affected sibships. Eur J Hum Genet 11:179–184
Hugot JP, Laurent-Puig P, Gower-Rousseau C et al (1996) Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379:821–823
Satsangi J, Parkes M, Louis E et al (1996) Two stage genomewide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199–202
Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606
Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603
Ahmad T, Tamboli CP, Jewell DP et al (2004) Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126:1533–1549
Girardin SE, Boneca IG, Viala J et al (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869–8872
Hugot JP (2004) Genetic origin of IBD. Inflamm Bowel Dis 10(Suppl 1):S11–S15
Lichtenberger GS, Flavell RA, Alexopoulou L (2004) Innate immunity and apoptosis in IBD. Inflamm Bowel Dis 10(Suppl 1):S58–S62
Lesage S, Zouali H, Cezard JP et al (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:745–747
Economou M, Trikalinos TA, Loizou KT et al (2004) Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99:2393–2404
Cuthbert AP, Fisher SA, Mirza MM et al (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867–874
Vermiere S, Wild G, Kocher K et al (2002) CARD15 genetic variation in a Quebec population: prevalence, genotype–phenotype relationship, and haplotype structure. Am J Hum Genet 71:74–83
Radlmayr M, Torok HP, Martin K et al (2002) The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn’s disease. Gastroenterology 122:2091–2092
Tukel T, Shalata A, Present D et al (2004) Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet 74(4):623–636
Van Heel D, Fisher S, Kirby A et al (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 13(7):763–770
Ogura Y, Inohara N, Benito A et al (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF (kappa) B. J Biol Chem 276:4812–4818
Derakhshan F, Naderi N, Farnood A et al (2008) Frequency of three common mutations of CARD15/NOD2 gene in Iranian IBD patients. Indian J Gastroenterol 27:8–11
Aghazadeh R, Zali MR, Bahari A et al (2005) Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 20:1691–1695
Farnood A, Naderi N, Moghaddam SJ et al (2007) The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int J Colorectal Dis 22:999–1003
Naderi N, Farnood A, Habibi M et al (2008) Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 23(12):1816–1822
Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6
Malchow H, Ewe K, Brandes JW et al (1984) European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment. Gastroenterology 86:249–266
Monkholm P, Binder V (2004) Clinical features and national history of Crohn's disease. In: Sartor RB, Sandborn WJ (eds) Kirsner's inflammatory bowel disease, 6th edn. Saunders, Philadelphia, pp 289–300
Sambrooks J, Fritsch EF, Manitis T (1992) Molecular cloning, laboratory manual. Cold Spring Harbor Laboratory Press, New York
Büning C, Genschel J, Bühner S et al (2004) Mutations in the NOD2 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther 19:1073–1078
Vavassori P, Borgiani P, Biancone L et al (2004) CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease. Inflamm Bowel Dis 10:116–121
Inoue N, Tamura K, Kinouchi Y et al (2002) Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology 123:86–91
Yamazaki K, Takazoe M, Tanaka T et al (2002) Absence of mutation in the NOD2 gene among 483 Japanese patients with Crohn’s disease. J Hum Genet 47:469–472
Figueroa C, Peralta A, Herrera L et al (2006) NOD2 and toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease. Eur Cytokine Netw 17:125–130
Russell RK, Drummond HE, Wilson DC et al (2008) Detailed assessment of NOD2 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesis. Genes Immun 9:556–560, Abstract
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naderi, N., Farnood, A., Habibi, M. et al. NOD2 exonic variations in Iranian Crohn's disease patients. Int J Colorectal Dis 26, 775–781 (2011). https://doi.org/10.1007/s00384-011-1145-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-011-1145-4